Tenet Healthcare (THC) Projected to Post Earnings on Thursday

Tenet Healthcare (NYSE:THC) will likely be posting its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect the company to announce earnings of $4.68 per share and revenue of $5.49 billion for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 29, 2026 at 10:00 AM ET.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating the consensus estimate of $4.26 by $1.86. The company had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.02 EPS. On average, analysts expect Tenet Healthcare to post $21.04 EPS for the current fiscal year and $20.81 EPS for the next fiscal year.

Tenet Healthcare Price Performance

Shares of THC opened at $268.59 on Tuesday. The company has a market cap of $21.63 billion, a price-to-earnings ratio of 10.36, a PEG ratio of 1.02 and a beta of 1.20. Tenet Healthcare has a 1-year low of $157.58 and a 1-year high of $283.05. The company’s fifty day simple moving average is $264.94 and its 200 day simple moving average is $219.01. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00.

Insider Buying and Selling

In other Tenet Healthcare news, Director Tammy Romo sold 4,922 shares of the stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30. Following the sale, the director directly owned 30,784 shares in the company, valued at $8,131,593.60. This represents a 13.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard J. Mark sold 10,000 shares of the stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the sale, the director owned 25,121 shares in the company, valued at $6,617,373.82. The trade was a 28.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 116,484 shares of company stock valued at $31,478,363 in the last ninety days. Insiders own 0.97% of the company’s stock.

Analyst Upgrades and Downgrades

THC has been the topic of a number of research analyst reports. Truist Financial upped their target price on shares of Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a report on Tuesday, July 28th. Guggenheim lifted their price target on Tenet Healthcare from $283.00 to $307.00 and gave the stock a “buy” rating in a report on Friday, October 16th. Wells Fargo & Company boosted their price target on Tenet Healthcare from $231.00 to $281.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Leerink Partners restated an “outperform” rating and issued a $309.00 price objective on shares of Tenet Healthcare in a research note on Friday, September 18th. Finally, Stephens reaffirmed an “overweight” rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research report on Monday, July 27th. Eighteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus target price of $278.45.

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.